Cerus (CERS) Work In Process (2013 - 2021)

Cerus (CERS) posted Work In Process of $6.7 million for Q2 2021, up 64.09% sequentially from $4.1 million in Q1 2021.

Cerus (CERS) Work In Process (2013 - 2021) Analysis & Trends

Cerus has reported Work In Process for 9 years, with the latest figure at $6.7 million in Q2 2021.

Quarterly Work In Process changed N/A year-over-year to $6.7 million in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $6.7 million (changed N/A YoY) and the FY2020 annual result came in at $5.1 million, down 1.22% from the prior year.
Work In Process grew to $6.7 million in Q2 2021 per CERS's latest filing, from $4.1 million in the prior quarter.
Over five years, Work In Process peaked at $6.7 million in Q2 2021 and troughed at $2.8 million in Q2 2018.
A 5-year average of $4.4 million and a median of $4.3 million in 2017 frame the typical range for Work In Process.
The sharpest annual moves came in 2018 and 2019: Work In Process decreased 29.85% in 2018, then soared 67.8% in 2019.
Over 5 years, Work In Process stood at $4.3 million in 2017, then declined by 28.47% to $3.1 million in 2018, then surged by 67.8% to $5.2 million in 2019, then declined by 1.22% to $5.1 million in 2020, then surged by 31.7% to $6.7 million in 2021.
According to Business Quant data, Work In Process over the past three periods registered $6.7 million, $4.1 million, and $5.1 million for Q2 2021, Q1 2021, and Q4 2020 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	Cerus	560.58 Mn	504.32 Mn	29.53 Mn

Download Data